Канада - Енглески - Health Canada

organon canada ltd ltee - ergotamine tartrate; caffeine; belladonna - tablet - 1mg; 100mg; .1mg - ergotamine tartrate 1mg; caffeine 100mg; belladonna .1mg - sympatholytic (adrenergic blocking) agents

Канада - Енглески - Health Canada

organon canada ltd ltee - ergotamine tartrate; caffeine; belladonna - suppository - 1mg; 100mg; .1mg - ergotamine tartrate 1mg; caffeine 100mg; belladonna .1mg - sympatholytic (adrenergic blocking) agents

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

bausch health us, llc - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - dihydroergotamine mesylate 4 mg in 1 ml - migranal (dihydroergotamine mesylate) nasal spray is indicated for the acute treatment of migraine headaches with or without aura. migranal (dihydroergotamine mesylate) nasal spray is not intended for the prophylactic therapy of migraine or for the management of hemiplegic or basilar migraine. there have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent cyp 3a4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities. the use of potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore contraindicated (see warnings, cyp 3a4 inhibitors ). migranal (dihydroergotamine mesylate) nasal spray should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or to p

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

truemed group llc - ergotamine tartrate (unii: mru5xh3b48) (ergotamine - unii:pr834q503t), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) -

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - ergotamine tartrate; caffeine - oral tablet - 1mg ; 100mg

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - ergotamine tartrate; caffeine - suppository - 2mg ; 100mg

Канада - Енглески - Health Canada

sandoz canada incorporated - dihydroergotamine mesylate - liquid - 1mg - dihydroergotamine mesylate 1mg - sympatholytic (adrenergic blocking) agents

Бангладеш - Енглески - DGDA (Directorate General of Drug Administration)

beximco pharmaceuticals ltd. - caffeine + ergotamine tartrate - suppository - 100 mg + 2 mg

Саудијска Арабија - Енглески - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - caffeine, ergotamine tartrate - tablet - 1 , 100 mg

Саудијска Арабија - Енглески - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

amdipharma, ireland - caffeine,ergotamine tartrate,hydrochlorothiazide,eprosartan mesilate - tablet - 100,1,12.5,600 mg,